Medical News

RSS

Some Iowa health care institutions have little oversight

The Des Moines Register looked at state regulation of health care institutions.

25 Apr 2011

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and launch of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System, the Company's third-generation drug-eluting stent technology.

25 Apr 2011

AstraZeneca selects Biologics as U.S. channel partner for vandetanib

Biologics, Inc., an integrated oncology management company, is pleased to announce it has been selected by AstraZeneca as the exclusive U.S. strategic channel partner for vandetanib.

25 Apr 2011

Supreme Court declines to expedite Virginia suit against health law

Virginia's challenge of the health law will need to take the normal route through federal appeals courts.

25 Apr 2011

Curemark CM-182 demonstrates positive results for schizophrenia in transgenic chakragati model of psychosis

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for schizophrenia in the transgenic chakragati (ckr) model of psychosis. The mouse model screening was performed by the Contract Research Organization, Cerca Insights.

25 Apr 2011

MACHC offers Phytel's Proactive Patient Outreach solution to members

Phytel, the leader in physician-led health improvement, and the Mid-Atlantic Association of Community Health Centers (MACHC) have formed a strategic partnership under which MACHC will support utilization of Phytel's population health management tools by its member community health centers in Maryland and Delaware.

25 Apr 2011

Child's death renews medical error debate

News outlets examine efforts to end hospital errors and a different case may challenge laws that protect military medical personnel from medical malpractice lawsuits.

25 Apr 2011

CryoLife's BioGlue Surgical Adhesive launched in Japan

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011.

25 Apr 2011

Adults with PTSD and history of childhood trauma have shorter telomeres

Adults with post-traumatic stress disorder and a history of childhood trauma had significantly shorter telomere length than those with PTSD but without childhood trauma, in a study by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

25 Apr 2011

Governors feeling the pinch on Medicaid funding

Medicaid was created in 1965 to provide health coverage for the poorest Americans, particularly those with children. States pay, on average, 43% of the tab for Medicaid. Washington pays the rest and, as part of the new health-care law, the federal government restricts states' ability to save money by narrowing eligibility for the program or charging more for coverage.

25 Apr 2011

MonoSol Rx, KemPharm enter development and commercialization partnership for ADHD prodrug

MonoSol Rx, LLC, the developer of PharmFilm® drug delivery technology, today announced that the Company has entered into a development and commercialization partnership with KemPharm, a biopharmaceutical company focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease.

25 Apr 2011

Mylan launches Letrozole Tablets for hormone receptor-positive early stage breast cancer

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Letrozole Tablets USP, 2.5 mg, under a previously announced settlement and license agreement with Novartis. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Letrozole Tablets and will market the product with a period of exclusivity.

25 Apr 2011

House Republicans face heat at home over proposed Medicare cuts

During the congressional recess, constituents have grilled some House Republicans on how deficit reduction proposals will affect Medicare. Meanwhile, Don Berwick says GOP plans deserve the "rationing" label more than the health law does.

25 Apr 2011

PDI extends eDetailing to mobile programs

PDI, Inc. today announced that Group DCA has expanded its proprietary DIAGRAM™ software platform to enable eDetail delivery on popular mobile devices including the iPad®, iPod touch® and iPhone® and Android™-based phones.

25 Apr 2011

Nausea and vomiting are most feared of all chemotherapy-related side effects

PediatRx, Inc. today commented on studies which reveal that chemotherapy-induced nausea and vomiting is one of the most feared of all chemotherapy-related side effects. The fear of nausea and subsequent vomiting is many times so significant that patients can develop a condition known as 'anticipatory' nausea, where the patient becomes nauseous primarily as a result of the fear of becoming nauseous.

25 Apr 2011

Pharmatek purchases spray dryer for drug formulation and manufacturing

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added spray drying to its drug formulation and manufacturing capabilities. The company has purchased a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture. This technology can be used for both oral and parenteral dosage forms.

25 Apr 2011

Planned Parenthood spends $400,000 on first-quarter lobbying

Planned Parenthood's federal lobbying bill more than tripled in the first three months of the new Congress, as Republicans targeted the group for funding cuts and transformed it into a political cause célébre.

25 Apr 2011

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANAT®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.

25 Apr 2011

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.

From QIAGEN Manchester Limited 25 Apr 2011

As practices change, family physician has trouble retiring

Dr. [Ronald] Sroka has practiced family medicine for 32 years in a small, red-brick building just six miles from his childhood home. ... Dr. Sroka, 62, thought about retiring. He tried to sell his once highly profitable practice. No luck. He tried giving it away. No luck. Dr. Sroka's fate is emblematic of a transformation in American medicine. ... [D]octors like him are increasingly being replaced by teams of rotating doctors and nurses who do not know their patients nearly as well. A centuries-old intimacy between doctor and patient is being lost.

25 Apr 2011